Patients with higher TBXT expression have significantly shorter progression-free survival than those with lower expression [24], and TBXT inhibits Paclitaxel-induced apoptosis in primary chordoma cell lines via carbonic anhydrase IX [25]. This evidence concerns the gene TBXT and chordoma.